ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous subtype of breast cancer that lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).